$HSIC Cashflow Statement | Understand Stock

$HSIC

$85.19 +$0.94 (1.12%) Live

$HSIC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 27, 2025	FY2024 12 months to Dec 28, 2024	FY2023 12 months to Dec 30, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 25, 2021
Cash flows from operating activities:
Net Income
Income from discontinued operations
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Impairment charge on intangible assets
Impairment of capitalized software
Non-cash restructuring and related charges
Gain on sale of equity investment
Stock-based compensation expense
Provision for losses on trade and other accounts receivable
Provision for (benefit from) deferred income taxes
Equity in earnings of affiliates
Distributions from equity affiliates
Changes in unrecognized tax benefits
Benefit from transition tax
Other
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable
Inventories
Other current assets
Accounts payable and accrued expenses

Net cash provided by operating activities from discontinued operations
Net cash provided by operating activities

Cash flows from investing activities:
Purchases of property and equipment
Payments related to equity investments and business acquisitions, net of cash acquired
Proceeds from sale of equity investment
Proceeds from loan to affiliate
Settlements for net investment hedges
Capitalized software costs
Other
Net cash used in investing activities from continuing operations
Net cash used in investing activities from discontinued operations
Net cash used in investing activities

Cash flows from financing activities:
Net change in bank credit lines
Proceeds from issuance of long-term debt
Principal payments for long-term debt
Debt issuance costs
Issuance of common stock
Debt extinguishment costs
Proceeds from issuance of stock upon exercise of stock options
Payments for repurchases and retirement of common stock
Payments for taxes related to shares withheld for employee taxes
Distribution received related to Animal Health Spin-off
Proceeds related to affiliates
Distributions to noncontrolling shareholders
Payments for contingent consideration
Acquisitions of noncontrolling interests in subsidiaries
Proceeds from Henry Schein Animal Health Business
Net cash provided by (used in) financing activities from discontinued operations
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents from discontinued operations
Net change in cash and cash equivalents from discontinued operations
Effect of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Comments